These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Empiric therapy for bacterial infections in neutropenic patients. Klastersky J Cancer Treat Res; 1995; 79():101-12. PubMed ID: 8746651 [No Abstract] [Full Text] [Related]
4. Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients? Hathorn JW; Pizzo PA J Antimicrob Chemother; 1986 Mar; 17 Suppl A():41-54. PubMed ID: 3519563 [TBL] [Abstract][Full Text] [Related]
8. New pathogens in neutropenic patients with cancer: an update for the new millennium. Zinner SH Int J Antimicrob Agents; 2000 Oct; 16(2):97-101. PubMed ID: 11053787 [TBL] [Abstract][Full Text] [Related]
9. Bacterial isolates from neutropenic febrile pediatric patients and their sensitivity patterns to antibiotics. Bhatti FN; Burney IA; Moid MI; Siddiqui T J Pak Med Assoc; 1998 Sep; 48(9):287-90. PubMed ID: 10028802 [TBL] [Abstract][Full Text] [Related]
10. The febrile neutropenic patient: newer options for empirical therapy. Rubin M; Walsh T; Butler K; Lee J; Lecciones J; Weinberger M; Roilides E; Gress J; Marshall D; Pizzo PA Haematol Blood Transfus; 1990; 33():531-8. PubMed ID: 2157645 [No Abstract] [Full Text] [Related]
11. Neutropenia, fever, and infection. Brown AE Am J Med; 1984 Mar; 76(3):421-8. PubMed ID: 6702873 [TBL] [Abstract][Full Text] [Related]
12. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia]. Jarque I; Sanz MA Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations. de Lalla F Drugs; 1997 May; 53(5):789-804. PubMed ID: 9129866 [TBL] [Abstract][Full Text] [Related]
14. Febrile neutropenia. Klastersky J Support Care Cancer; 1993 Sep; 1(5):233-9. PubMed ID: 8156232 [TBL] [Abstract][Full Text] [Related]
15. Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan. Khan MA; Siddiqui BK; Shamim A; Yosuf MA; Ahmed U; Zakiullah N; Burney IA J Pak Med Assoc; 2004 Jul; 54(7):357-60. PubMed ID: 15449917 [TBL] [Abstract][Full Text] [Related]
16. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520 [TBL] [Abstract][Full Text] [Related]
17. The role of gram-positive therapy in the neutropenic patient. Menichetti F; Del Favero A J Antimicrob Chemother; 1991 Apr; 27 Suppl B():51-60. PubMed ID: 1829077 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of infections in cancer patients: a review. Sim SK Am J Hosp Pharm; 1975 Jan; 32(1):35-44. PubMed ID: 1092159 [TBL] [Abstract][Full Text] [Related]
19. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Rubin M; Hathorn JW; Marshall D; Gress J; Steinberg SM; Pizzo PA Ann Intern Med; 1988 Jan; 108(1):30-5. PubMed ID: 3337513 [TBL] [Abstract][Full Text] [Related]
20. Infectious complications in the cancer patient. Bodey GP Curr Probl Cancer; 1977 Jun; 1(12):1-63. PubMed ID: 406117 [No Abstract] [Full Text] [Related] [Next] [New Search]